Although our study showed the titer of autoantibodies against GRP78 in early-HCC, LC, and CH groups was significantly higher than NHS group, there was no difference among early-HCC, LC, and CH groups. The gene discussed is HSPA5; the disease is hepatocellular carcinoma.